Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
MRM Health in a €55 million Series B financing round led by Biocodex, joined by Athos, BNP Paribas Fortis Private Equity, SFPIM, AvH, OMX, Qbic, VIB

MRM Health in a €55 million Series B financing round led by Biocodex, joined by Athos, BNP Paribas Fortis Private Equity, SFPIM, AvH, OMX, Qbic, VIB

Health services Pharma

Germany

France

United States

Belgium

Investments

01 September 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

MRM Health (company)

Belgium

Health services Pharma

Total investments received (USD): 64.08M

Round value (USD): 64.08M

Round investors: SFPIM Athos Service VIB OMX Ventures BNP Paribas Fortis Private Equity Qbic Biocodex Ackermans & van Haaren

Company: MRM Health

Industry: Health services Pharma

Related deals

NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

Biotech Health services Pharma

Spain

Switzerland

United Kingdom

Netherlands

United States

Australia

Investments 01 September 2025

ViCentra raised €72m in Series D funding led by Innovation Industries, w/ Partners in Equity, Invest-NL, and EQT Life Sciences and Health Innovations.

Health services Pharma

Sweden

Netherlands

Investments 29 August 2025

Aerospacelab closed a €94M Series B, €38M of which a commitment from the European Investment Bank

Airline Industry Manufacturing Telecom Transportation

France

Belgium

Investments 11 August 2025

ProVerum raised $80m in a B round led by MVM Partners, joined by OrbiMed, Ireland Strategic Investment Fund, Gilde, Lightstone Ventures, Atlantic Bridge

Health services Manufacturing Pharma

United Kingdom

Ireland

Netherlands

United States

Investments 10 August 2025

Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital

Biotech Health services Manufacturing Pharma

Switzerland

Germany

France

United Kingdom

Belgium

Italy

Japan

Investments 01 July 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top